U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206118
Company: PAI HOLDINGS PHARM
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/09/2017 ORIG-1 Approval STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/17/2020 SUPPL-2 Labeling-Patient Package Insert, Labeling-Package Insert

Label is not available on this site.

04/17/2020 SUPPL-1 Labeling-Package Insert

Label is not available on this site.

BETAMETHASONE DIPROPIONATE

OINTMENT, AUGMENTED;TOPICAL; EQ 0.05% BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription No AB 074304 ACTAVIS MID ATLANTIC
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription No AB 075373 FOUGERA PHARMS
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription No AB 209106 LUPIN LTD
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription No AB 206118 PAI HOLDINGS PHARM
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription No AB 076753 TARO
DIPROLENE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription Yes AB 018741 ORGANON
Back to Top